Xuefeng Wu
- Cancer Research top 2%
- NF-κB Signaling Pathways 14
- Immunology top 2%
- Immune Cell Function and Interaction 9
- interferon and immune responses 7
- Immune Response and Inflammation 7
- Immunotherapy and Immune Responses 4
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 9
- Inflammasome and immune disorders 5
- Oncology top 10%
- Cancer-related Molecular Pathways 4
- Epidemiology top 10%
Xuefeng Wu
40 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 684
- Immunology 953
- Molecular Biology 1.2k
- Oncology 445
- Epidemiology 268
Countries citing papers authored by Xuefeng Wu
This map shows the geographic impact of Xuefeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Wu more than expected).
Fields of papers citing papers by Xuefeng Wu
This network shows the impact of papers produced by Xuefeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Wu. The network helps show where Xuefeng Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuefeng Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 16 | |
| 6 | 2022 | 34 | |
| 7 | 2021 | 54 | |
| 8 | 2020 | 46 | |
| 9 | 2019 | 18 | |
| 10 | 2017 | 109 | |
| 11 | 2014 | 38 | |
| 12 | 2014 | 57 | |
| 13 | 2013 | 15 | |
| 14 | 2011 | 17 | |
| 15 | 2011 | 24 | |
| 16 | 2011 | 164 | |
| 17 | 2010 | 28 | |
| 18 | 2008 | 107 | |
| 19 | 2007 | 58 | |
| 20 | 2006 | 18 |
About Xuefeng Wu
Xuefeng Wu is a scholar working on Immunology, Cancer Research and Physiology, having authored 42 papers that have together received 2.0k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (14 papers), Ubiquitin and proteasome pathways (9 papers), Immune Cell Function and Interaction (9 papers), interferon and immune responses (7 papers), Immune Response and Inflammation (7 papers), Inflammasome and immune disorders (5 papers), Immunotherapy and Immune Responses (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (684 citations), Immunology (953 citations) and Molecular Biology (1.2k citations). Xuefeng Wu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Shao‐Cong Sun, Minying Zhang, Michael Karin, William W. Reiley, Erica L. Granger, Wei Jin, Mikyoung Chang, Andrew Lee, Xuhong Cheng and Hongbo Hu. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.